These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37223101)

  • 1. A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models.
    Chettab K; Fitzsimmons C; Novikov A; Denis M; Phelip C; Mathé D; Choffour PA; Beaumel S; Fourmaux E; Norca P; Kryza D; Evesque A; Jordheim LP; Perrial E; Matera EL; Caroff M; Kerzerho J; Dumontet C
    Front Immunol; 2023; 14():1066402. PubMed ID: 37223101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
    Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
    Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages.
    Richert I; Berchard P; Abbes L; Novikov A; Chettab K; Vandermoeten A; Dumontet C; Karanian M; Kerzerho J; Caroff M; Blay JY; Dutour A
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An agonistic anti-Toll-like receptor 4 monoclonal antibody as an effective adjuvant for cancer immunotherapy.
    Tsukamoto H; Kubota K; Shichiku A; Maekawa M; Mano N; Yagita H; Ohta S; Tomioka Y
    Immunology; 2019 Oct; 158(2):136-149. PubMed ID: 31515801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory cytokines induce lipopolysaccharide tolerance in human monocytes without modifying toll-like receptor 4 membrane expression.
    Moreno C; Merino J; Vázquez B; Ramírez N; Echeverría A; Pastor F; Sánchez-Ibarrola A
    Scand J Immunol; 2004 Jun; 59(6):553-8. PubMed ID: 15182250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure to hydroxyapatite nanoparticles enhances Toll-like receptor 4 signal transduction and overcomes endotoxin tolerance in vitro and in vivo.
    Hua Y; Wu J; Wu H; Su C; Li X; Ao Q; Zeng Q; Zhu X; Zhang X
    Acta Biomater; 2021 Nov; 135():650-662. PubMed ID: 34525415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.
    Mata-Haro V; Cekic C; Martin M; Chilton PM; Casella CR; Mitchell TC
    Science; 2007 Jun; 316(5831):1628-32. PubMed ID: 17569868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Binge Alcohol Intake Inhibits TLR4-MyD88 and TLR4-TRIF Responses but Not the TLR3-TRIF Pathway: HspA1A and PP1 Play Selective Regulatory Roles.
    Muralidharan S; Lim A; Catalano D; Mandrekar P
    J Immunol; 2018 Apr; 200(7):2291-2303. PubMed ID: 29445009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Class of Small Molecule Agonists with Preference for Human over Mouse TLR4 Activation.
    Marshall JD; Heeke DS; Rao E; Maynard SK; Hornigold D; McCrae C; Fraser N; Tovchigrechko A; Yu L; Williams N; King S; Cooper ME; Hajjar AM; Woo JC
    PLoS One; 2016; 11(10):e0164632. PubMed ID: 27736941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monophosphoryl lipid A induces protection against LPS in medullary thick ascending limb through a TLR4-TRIF-PI3K signaling pathway.
    Watts BA; George T; Sherwood ER; Good DW
    Am J Physiol Renal Physiol; 2017 Jul; 313(1):F103-F115. PubMed ID: 28356284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polygonatum Polysaccharide Regulates Macrophage Polarization and Improves LPS-Induced Acute Lung Injury through TLR4-MAPK/NF-
    Zhou W; Hong J; Liu T; Li M; Jin H; Wang X
    Can Respir J; 2022; 2022():2686992. PubMed ID: 35874106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-specific modulation of the immune response with liposomal meningococcal lipopolysaccharide: role of different cells and cytokines.
    Petrov AB; Kolenko VM; Koshkina NV; Zakirov MM; Bugaev LV; Semenova IB; Wiertz EJ; Poolman JT
    Vaccine; 1994 Sep; 12(12):1064-70. PubMed ID: 7998414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery.
    Gregg KA; Harberts E; Gardner FM; Pelletier MR; Cayatte C; Yu L; McCarthy MP; Marshall JD; Ernst RK
    mBio; 2017 May; 8(3):. PubMed ID: 28487429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-1,4-mannobiose stimulates innate immune responses and induces TLR4-dependent activation of mouse macrophages but reduces severity of inflammation during endotoxemia in mice.
    Kovacs-Nolan J; Kanatani H; Nakamura A; Ibuki M; Mine Y
    J Nutr; 2013 Mar; 143(3):384-91. PubMed ID: 23343679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chloroquine protects mice from challenge with CpG ODN and LPS by decreasing proinflammatory cytokine release.
    Hong Z; Jiang Z; Liangxi W; Guofu D; Ping L; Yongling L; Wendong P; Minghai W
    Int Immunopharmacol; 2004 Feb; 4(2):223-34. PubMed ID: 14996414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pellino-1 Positively Regulates Toll-like Receptor (TLR) 2 and TLR4 Signaling and Is Suppressed upon Induction of Endotoxin Tolerance.
    Murphy M; Xiong Y; Pattabiraman G; Qiu F; Medvedev AE
    J Biol Chem; 2015 Jul; 290(31):19218-32. PubMed ID: 26082489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flagellin or lipopolysaccharide treatment modified macrophage populations after colorectal radiation of rats.
    Lacavé-Lapalun JV; Benderitter M; Linard C
    J Pharmacol Exp Ther; 2013 Jul; 346(1):75-85. PubMed ID: 23596059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomal lipopolysaccharide initiates TRIF-dependent signaling pathway independent of CD14.
    Watanabe S; Kumazawa Y; Inoue J
    PLoS One; 2013; 8(4):e60078. PubMed ID: 23565187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunobiology of toll-like receptor 4 agonists: from endotoxin tolerance to immunoadjuvants.
    Bohannon JK; Hernandez A; Enkhbaatar P; Adams WL; Sherwood ER
    Shock; 2013 Dec; 40(6):451-62. PubMed ID: 23989337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant activity of naturally occurring monophosphoryl lipopolysaccharide preparations from mucosa-associated bacteria.
    Chilton PM; Hadel DM; To TT; Mitchell TC; Darveau RP
    Infect Immun; 2013 Sep; 81(9):3317-25. PubMed ID: 23798540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.